Search
Jinling Pharmaceutical: Oragolid Tablets Approved for Phase III Clinical Trial Milestone
2 week ago /
Read about 0 minute
Author：小编
Jinling Pharmaceutical has announced a significant advancement, as its subsidiary, Jinling Pharmaceutical Factory, has recently secured the Approval Notice for Drug Clinical Trial from the National Medical Products Administration. This pivotal approval marks the official commencement of Phase III clinical trials for Oragolid Tablets, a medication primarily designed to alleviate moderate to severe pain associated with endometriosis.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
